French pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health unit Opella to a US investment fund, after providing the French government with guarantees on maintaining jobs and production within France.
The post Sanofi pursues sale of France’s leading painkiller to US investment fund after controversy appeared first on World Online.